title: De novo FTL mutation: a clinical, neuroimaging, and molecular study.
authors.forename: Eugenia
authors.initials: E
authors.lastname: Storti
authors.forename: Francesca
authors.initials: F
authors.lastname: Cortese
authors.forename: Roberto
authors.initials: R
authors.lastname: Di Fabio
authors.forename: Chiara
authors.initials: C
authors.lastname: Fiorillo
authors.forename: Alberto
authors.initials: A
authors.lastname: Pierallini
authors.forename: Alessandra
authors.initials: A
authors.lastname: Tessa
authors.forename: Annamaria
authors.initials: A
authors.lastname: Valleriani
authors.forename: Francesco
authors.initials: F
authors.lastname: Pierelli
authors.forename: Filippo M
authors.initials: FM
authors.lastname: Santorelli
authors.forename: Carlo
authors.initials: C
authors.lastname: Casali
mesh_terms: D000328:Adult; D001921:Brain / Q000473:pathology; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D000077543:Deferiprone; D018491:Dopamine Agonists / Q000627:therapeutic use; D006801:Humans; D019189:Iron Metabolism Disorders / Q000235:genetics* / Q000473:pathology* / Q000523:psychology; D008279:Magnetic Resonance Imaging; D008297:Male; D009069:Movement Disorders / Q000235:genetics* / Q000473:pathology*; D009154:Mutation / Q000235:genetics*; D019150:Neuroaxonal Dystrophies / Q000235:genetics* / Q000473:pathology* / Q000523:psychology; D059906:Neuroimaging; D011728:Pyridones / Q000627:therapeutic use; D017211:Treatment Failure; D014202:Tremor / Q000209:etiology; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000235:genetics*
chemical_list: D018680:Cholinergic Antagonists; D018491:Dopamine Agonists; D011728:Pyridones; D000077543:Deferiprone; C501162:FLT1 protein, human; D040281:Vascular Endothelial Growth Factor Receptor-1